Valuation
- Market cap
- —
- Revenue TTM
- $0
- Net income TTM
- $0
- P/E (trailing)
- —
- P/E (forward)
- —
- Profit margin
- 0.00%
- Debt to equity
- —
Trading
- Volume
- 300
- Avg volume
- 1,830
- Day's range
- $1.97 – $2.01
- Shares out
- —
- Stochastic %K
- 28%
- Beta
- —
- Analysts
- —
- Price target
- —
Company profile
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related c...
Show more
Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.
- Industry
- Medical Instruments & Supplies
- Sector
- Healthcare
- Phone
- 61 2 8063 1600
- Website
- https://www.nanosonics.com.au
- Address
- Building A, Level 1 7-11 Talavera Road, Macquarie Park, Australia
Latest news
No headlines yet.
